Finance

Beta
Lists
CLN:WSE
Celon Pharma SA
PLN 20.50
0.00%
(0.00) 1D
Jun 5, 5:00:02 PM GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for CLN...
Open
PLN 20.35
High
PLN 20.65
Low
PLN 20.35
Mkt. cap
1.10B
Avg. vol.
7.88K
Volume
9.09K
P/E ratio
10.15
52-wk high
PLN 25.30
52-wk low
PLN 18.50
EPS
PLN 2.02
Shares outstanding
53.86M
No. of employees
564
Open
PLN 20.35
High
PLN 20.65
Low
PLN 20.35
Mkt. cap
1.10B
Avg. vol.
7.88K
Volume
9.09K
P/E ratio
10.15
52-wk high
PLN 25.30
52-wk low
PLN 18.50
EPS
PLN 2.02
Shares outstanding
53.86M
No. of employees
564
News stories
From sources across the web
About Celon Pharma SA
CEO-
Employees564
Founded2002
Headquarters-
SectorPharmaceutical industry
Last report
May 20, 2026
Fiscal period
Q1 2026
EPS / Est. (PLN)
- / -
Revenue / Est. (PLN)
61.86M / 60.50M
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in PLN
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
55.82M
71.13M
64.34M
61.86M
Cost of goods sold
20.26M
16.83M
-
16.70M
Cost of revenue
20.26M
16.83M
-
16.70M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35.01M
33.02M
-
36.08M
Operating expense
52.22M
46.24M
-
51.14M
Total operating expenses
72.48M
63.07M
-
67.84M
Operating income
-16.67M
8.06M
-
-5.98M
Other non operating income
-
-30.00K
-
169.28M
EBT including unusual items
-26.84M
-2.77M
-
160.34M
EBT excluding unusual items
-26.84M
-2.77M
-
160.34M
Income tax expense
5.92M
-6.43M
-
-2.26M
Effective tax rate
-22.05%
232.29%
-
-1.41%
Other operating expenses
5.98M
2.20M
-
3.93M
Net income
-32.76M
3.66M
-
162.60M
Net profit margin
-58.70%
5.15%
-
262.82%
Earnings per share
-
-
-
-
Interest and investment income
550.00K
-
-
-
Interest expense
-304.00K
-
-
-952.00K
Net interest expenses
246.00K
-
-
-952.00K
Depreciation and amortization charges
11.23M
11.01M
-
11.13M
EBITDA
-8.28M
16.34M
-
5.16M
Gain or loss from assets sale
2.53M
-170.00K
-
-569.00K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more